The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participants
- 30 September 2003
- journal article
- Published by Elsevier in Annals of Epidemiology
- Vol. 13 (9) , S78-S86
- https://doi.org/10.1016/s1047-2797(03)00045-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A Clinical Trial of Estrogen-Replacement Therapy after Ischemic StrokeNew England Journal of Medicine, 2001
- Effects of Estrogen Replacement on the Progression of Coronary-Artery AtherosclerosisNew England Journal of Medicine, 2000
- Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus ProgestinJNCI Journal of the National Cancer Institute, 2000
- Overview of Women's Decision Making Regarding Elective Hysterectomy, Oophorectomy, and Hormone Replacement TherapyJournal of Women's Health & Gender-Based Medicine, 2000
- Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer RiskJAMA, 2000
- Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.Archives of internal medicine (1960), 1999
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Design of the Women’s Health Initiative Clinical Trial and Observational StudyControlled Clinical Trials, 1998
- Epidemiology of Hysterectomy in the United States: Demographic and Reproductive Factors in a Nationally Representative SampleJournal of Women's Health, 1997
- Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI TrialJAMA, 1995